CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer

Clinical trial NCT04062708 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04062708
Sponsor: Alliance Foundation Trials, LLC.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Stage IIIA Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer

Start date: 2021-03-10
Primary completion: 2026-07-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.